Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: Relationship to the endocrine phenotype of adenoma

Folia Histochemica et Cytobiologica

Volumn 44, Issue 1, 2006, Pages 37-41

  Pawlikowski, Marek ^a   Gruszka, Anna ^a   Kurnatowska, Ilona ^a   Winczyk, Katarzyna ^a   Kunert Radek, Jolanta ^a   Radek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Immunohistochemistry; PCNA; Pituitary adenomas

Indexed keywords

CORTICOTROPIN; CYCLINE; FOLLITROPIN; GROWTH HORMONE; HORMONE ANTIBODY; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSHING DISEASE; ENDOCRINE TUMOR; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PREDICTION; PROGNOSIS; PROLACTINOMA; PROTEIN EXPRESSION; TUMOR RECURRENCE;

EID: 32444448832     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Blevins LS Jr, Verity DK, Allen G (1998) Aggressive pituitary tumors. Oncology 12:1307-1312
2. Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET (1996) Flow cytometric DNA ploidy and cell phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Gen Diagn Pathol 142: 89-95
3. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J Clin Endocrinol Metab 82:2102-2107
4. Desai B, Burrin JM, Nott CA, Geddes JF, Lamb EJ, Aylwin SJB, Wood DF, Thakkar C, Monson JP (1995) Glycoprotein alpha-subunit production and plurihormonality in human corticotroph tumours - an in vitro and immunohistochemical study. Eur J Endocrinol 133: 25-32
5. Gandour-Edwards R, Kapadia SB, Janecka IB, Martinez AJ, Barnes L (1995) Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 8: 160-164
6. Hsu DW, Hakim F, Biller BM, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET (1993) Significance of proliferating cell nuclear antigen index in predicting pituitary recurrence. J Neurosurg 78: 753-761
7. Ibrahim AE, Pickering RM, Gawne-Cain ML, King S, Lees PD, Ellison DW (2004) Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas. Clin Neuropathol 23: 8-15
8. Kasperlik-Zaluska AA, Nielubowicz J, Wislawski J, Hartwig W, Zaluska J, Jeske W, Migdalska B (1983) Nelson's syndrome: incidence and prognosis. Clin Endocrinol 19: 693-698
9. Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T (1995) Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas. Acta Neurochir 136: 37-43
10. Klencki M, Kurnatowska I, Słowińska-Klencka D, Lewiński A, Pawlikowski M (2001) Correlation between PCNA expression and AgNOR dots in pituitary adenomas. Endocr Pathol 12: 163-169
11. Kovacs K, Horvath E, Kerenyi NA, Sheppard RH (1976) Light and electron microscopic features of a pituitary adenoma in Nelson's syndrome. Am J Clin Pathol 65: 337-343
12. Losa M, Franzin A, Mortini P, Terreni MR, Mangili F, Giovanelli M (1998) Usefulness of markers of cell proliferation in the management of pituitary adenomas. Clin Sci (London) 95: 129-135
13. Nelson DH, Sprumt GI, Mims RB (1966) Plasma ACTH determinations in 58 patients before and after adrenalectomy for Cushing syndrome. J Clin Endocrinol 26: 722-728
14. Nose-Alberti V, Mesquita MI, Martin LC, Kayath MJ (1998) Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 9: 53-62
15. Otsuka F, Tamiya T, Yamauchi T, Ogura T, Ohmoto T, Makino H (1999) Quantitative analysis of growth-related factors in human pituitary adenomas: lowered insulin-like growth factor-I and its receptor mRNA in growth hormone producing adenomas. Regul Pept 31: 31-38
16. Pawlikowski M (2001) Immunocytochemical prognostic markers in pituitary adenomas. Folia Histochem Cytobiol 39: 105-106
17. Schreiber S, Saeger W, Ludecke DK (1999) Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1: 213-220
18. Trouillas J, Delgrange E, Jouanneau E, Meiter D, Guigard MP, Donicker J, Perrin G, Jan M, Tourniaire J (2000) Prolactinoma in man: clinical and histological characteristics (in French). Ann Endocrinol 61: 253-257
19. Turner HE, Wass JA (1999) Are markers of proliferation valuable in the histological assessement of pituitary tumours? Pituitary 1: 147-151